insights_auto
Miks on ALNOV langenud? 3,30%?
Uurige põhjalikumaltchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
−3,30%(−0,014) 1 p
20. nov, 17:35:10 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALNOV põhistatistika genereerimine…
Ava
0,43 €
Kõrge
0,44 €
Madal
0,42 €
Turu kapit.
28,77 mln
Keskm. maht
128,00 tuh
Maht
64,11 tuh
52 näd kõrgeim
1,04 €
52 näd madalaim
0,29 €
Aktsiatulu
−0,37 €
Käibivad aktsiad
72,59 mln
Töötajate arv
228
Ava
0,43 €
Kõrge
0,44 €
Madal
0,42 €
Turu kapit.
28,77 mln
Keskm. maht
128,00 tuh
Maht
64,11 tuh
52 näd kõrgeim
1,04 €
52 näd madalaim
0,29 €
Aktsiatulu
−0,37 €
Käibivad aktsiad
72,59 mln
Töötajate arv
228
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
52 minuti eest
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
13 minuti eest
The S&P 500 Is Having the Longest Losing Streak Since February 2020
The Motley Fool
·
1 tunni eest
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
Beinsure
·
10 tunni eest
Dow Jones today: What’s next for stocks in 2027 after an 8% weekly crash?
Profiil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Teave üksuse Novacyt SA kohta
TegevjuhtDavid Allmond
Töötajad228
Asutatud3. juuli 2006
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitnovacyt.com